Pharmacogenomics of Vincristine‐Induced Peripheral Neuropathy Implicates Pharmacokinetic and Inherited Neuropathy Genes

Vincristine is an effective chemotherapeutic drug for various cancers, including acute lymphoblastic leukemia (ALL). Unfortunately, clinical utility is restricted by dose‐limiting vincristine‐induced peripheral neuropathies (VIPN). We sought to determine the association of VIPN with a recently ident...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical pharmacology and therapeutics 2019-02, Vol.105 (2), p.402-410
Hauptverfasser: Wright, Galen E.B., Amstutz, Ursula, Drögemöller, Britt I., Shih, Joanne, Rassekh, Shahrad R., Hayden, Michael R., Carleton, Bruce C., Ross, Colin J.D., Visscher, Henk, Aminkeng, Folefac, Higginson, Michelle, Massah, Nasim, Miao, Fudan, Bhavsar, Amit, Lee, Jong, Bendyshe‐Walton, Tessa, Tanoshima, Reo, Johnson, David, Zhuwaki, Carnation, Honcharik, Nick, Jong, Geert‘t, Israels, Sara, Staub, Michelle, Rieder, Michael, Faught, Lauren, Ito, Shinya, Nathan, Paul, Karande, Smita, Vaillancourt, Régis, Johnston, Donna, Nguyen, Kimmy, Bussières, Jean‐François, Lebel, Denis, Jean‐Louis, Jennifer
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 410
container_issue 2
container_start_page 402
container_title Clinical pharmacology and therapeutics
container_volume 105
creator Wright, Galen E.B.
Amstutz, Ursula
Drögemöller, Britt I.
Shih, Joanne
Rassekh, Shahrad R.
Hayden, Michael R.
Carleton, Bruce C.
Ross, Colin J.D.
Visscher, Henk
Aminkeng, Folefac
Higginson, Michelle
Massah, Nasim
Miao, Fudan
Bhavsar, Amit
Lee, Jong
Bendyshe‐Walton, Tessa
Tanoshima, Reo
Johnson, David
Zhuwaki, Carnation
Honcharik, Nick
Jong, Geert‘t
Israels, Sara
Staub, Michelle
Rieder, Michael
Faught, Lauren
Ito, Shinya
Nathan, Paul
Karande, Smita
Vaillancourt, Régis
Johnston, Donna
Nguyen, Kimmy
Bussières, Jean‐François
Lebel, Denis
Jean‐Louis, Jennifer
description Vincristine is an effective chemotherapeutic drug for various cancers, including acute lymphoblastic leukemia (ALL). Unfortunately, clinical utility is restricted by dose‐limiting vincristine‐induced peripheral neuropathies (VIPN). We sought to determine the association of VIPN with a recently identified risk variant, CEP72 rs924607, and drug absorption, distribution, metabolism, and excretion (ADME) gene variants in pediatric ALL. This was followed by a meta‐analysis of pharmacogenomic data from over 500 patients. CEP72 rs924607 was significantly associated with VIPN (P = 0.02; odds ratio (OR) = 3.4). ADME analyses identified associations between VIPN and ABCC1 rs3784867 (P = 5.34 × 10−5; OR = 4.9), and SLC5A7 rs1013940 (P = 9.00 × 10−4; OR= 8.6); genes involved in vincristine transport and inherited neuropathies, respectively. Meta‐analysis identified an association with a variant related to TTPA (rs10504361: P = 6.85 × 10−4; OR = 2.0), a heritable neuropathy‐related gene. This study provides essential corroboratory evidence for CEP72 rs924607 and highlights the importance of drug transporter and inherited neuropathy genes in VIPN.
doi_str_mv 10.1002/cpt.1179
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6519044</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2068925744</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4109-b700b8f4178d3a7f3f159ed124dd0c0b1055b03d6e99c290f411acdae7d365053</originalsourceid><addsrcrecordid>eNp1kctO3DAUhi1EBVNA4glQlmwCx0mcxBukasRlJNTOAthajn3CuE3s1E5As-sj9Bl5kpqrpgu8sSx__-dj_YQcUjihANmpGsYTSiu-RWaU5VlaspxtkxkA8JRneblLvobwMx4LXtc7ZDfjcTFazsh6uZK-l8rdo3W9USFxbXJnrPImjMbi05-_C6snhTpZojfDCr3sku84eTfIcbVOFv3QGSVHDMm76lfMjUYl0upkYWPCjDG-kblEi2GffGllF_Dgbd8jtxfnN_Or9PrH5WL-7TpVBY3jNxVAU7cFrWqdy6rNW8o4apoVWoOChgJjDeS6RM5VxiGSVCotsdJ5yYDle-Ts1TtMTY9aoR3jF8TgTS_9WjhpxP831qzEvXsQJaMciiIKjt8E3v2eMIyiN0Fh10mLbgoig7LmGas2UeVdCB7bj2coiOemRGxKPDcV0aPNsT7A92oikL4Cj6bD9aciMV_evAj_ARD3ods</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2068925744</pqid></control><display><type>article</type><title>Pharmacogenomics of Vincristine‐Induced Peripheral Neuropathy Implicates Pharmacokinetic and Inherited Neuropathy Genes</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Wright, Galen E.B. ; Amstutz, Ursula ; Drögemöller, Britt I. ; Shih, Joanne ; Rassekh, Shahrad R. ; Hayden, Michael R. ; Carleton, Bruce C. ; Ross, Colin J.D. ; Visscher, Henk ; Aminkeng, Folefac ; Higginson, Michelle ; Massah, Nasim ; Miao, Fudan ; Bhavsar, Amit ; Lee, Jong ; Bendyshe‐Walton, Tessa ; Tanoshima, Reo ; Johnson, David ; Zhuwaki, Carnation ; Honcharik, Nick ; Jong, Geert‘t ; Israels, Sara ; Staub, Michelle ; Rieder, Michael ; Faught, Lauren ; Ito, Shinya ; Nathan, Paul ; Karande, Smita ; Vaillancourt, Régis ; Johnston, Donna ; Nguyen, Kimmy ; Bussières, Jean‐François ; Lebel, Denis ; Jean‐Louis, Jennifer</creator><creatorcontrib>Wright, Galen E.B. ; Amstutz, Ursula ; Drögemöller, Britt I. ; Shih, Joanne ; Rassekh, Shahrad R. ; Hayden, Michael R. ; Carleton, Bruce C. ; Ross, Colin J.D. ; Visscher, Henk ; Aminkeng, Folefac ; Higginson, Michelle ; Massah, Nasim ; Miao, Fudan ; Bhavsar, Amit ; Lee, Jong ; Bendyshe‐Walton, Tessa ; Tanoshima, Reo ; Johnson, David ; Zhuwaki, Carnation ; Honcharik, Nick ; Jong, Geert‘t ; Israels, Sara ; Staub, Michelle ; Rieder, Michael ; Faught, Lauren ; Ito, Shinya ; Nathan, Paul ; Karande, Smita ; Vaillancourt, Régis ; Johnston, Donna ; Nguyen, Kimmy ; Bussières, Jean‐François ; Lebel, Denis ; Jean‐Louis, Jennifer ; Canadian Pharmacogenomics Network for Drug Safety Consortium ; The Canadian Pharmacogenomics Network for Drug Safety Consortium</creatorcontrib><description>Vincristine is an effective chemotherapeutic drug for various cancers, including acute lymphoblastic leukemia (ALL). Unfortunately, clinical utility is restricted by dose‐limiting vincristine‐induced peripheral neuropathies (VIPN). We sought to determine the association of VIPN with a recently identified risk variant, CEP72 rs924607, and drug absorption, distribution, metabolism, and excretion (ADME) gene variants in pediatric ALL. This was followed by a meta‐analysis of pharmacogenomic data from over 500 patients. CEP72 rs924607 was significantly associated with VIPN (P = 0.02; odds ratio (OR) = 3.4). ADME analyses identified associations between VIPN and ABCC1 rs3784867 (P = 5.34 × 10−5; OR = 4.9), and SLC5A7 rs1013940 (P = 9.00 × 10−4; OR= 8.6); genes involved in vincristine transport and inherited neuropathies, respectively. Meta‐analysis identified an association with a variant related to TTPA (rs10504361: P = 6.85 × 10−4; OR = 2.0), a heritable neuropathy‐related gene. This study provides essential corroboratory evidence for CEP72 rs924607 and highlights the importance of drug transporter and inherited neuropathy genes in VIPN.</description><identifier>ISSN: 0009-9236</identifier><identifier>EISSN: 1532-6535</identifier><identifier>DOI: 10.1002/cpt.1179</identifier><identifier>PMID: 29999516</identifier><language>eng</language><publisher>United States: John Wiley and Sons Inc</publisher><subject>Antineoplastic Agents, Phytogenic - pharmacokinetics ; Antineoplastic Agents, Phytogenic - toxicity ; Child ; Child, Preschool ; Computational Biology ; Female ; Humans ; Male ; Microtubule-Associated Proteins - genetics ; Multidrug Resistance-Associated Proteins - genetics ; Peripheral Nervous System Diseases - chemically induced ; Peripheral Nervous System Diseases - genetics ; Pharmacogenetics ; Tissue Distribution ; Vincristine - pharmacokinetics ; Vincristine - toxicity</subject><ispartof>Clinical pharmacology and therapeutics, 2019-02, Vol.105 (2), p.402-410</ispartof><rights>2018 The Authors Clinical Pharmacology &amp; Therapeutics published by Wiley Periodicals, Inc. on behalf of American Society for Clinical Pharmacology and Therapeutics</rights><rights>2018 The Authors Clinical Pharmacology &amp; Therapeutics published by Wiley Periodicals, Inc. on behalf of American Society for Clinical Pharmacology and Therapeutics.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4109-b700b8f4178d3a7f3f159ed124dd0c0b1055b03d6e99c290f411acdae7d365053</citedby><cites>FETCH-LOGICAL-c4109-b700b8f4178d3a7f3f159ed124dd0c0b1055b03d6e99c290f411acdae7d365053</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fcpt.1179$$EPDF$$P50$$Gwiley$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fcpt.1179$$EHTML$$P50$$Gwiley$$Hfree_for_read</linktohtml><link.rule.ids>230,314,776,780,881,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29999516$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wright, Galen E.B.</creatorcontrib><creatorcontrib>Amstutz, Ursula</creatorcontrib><creatorcontrib>Drögemöller, Britt I.</creatorcontrib><creatorcontrib>Shih, Joanne</creatorcontrib><creatorcontrib>Rassekh, Shahrad R.</creatorcontrib><creatorcontrib>Hayden, Michael R.</creatorcontrib><creatorcontrib>Carleton, Bruce C.</creatorcontrib><creatorcontrib>Ross, Colin J.D.</creatorcontrib><creatorcontrib>Visscher, Henk</creatorcontrib><creatorcontrib>Aminkeng, Folefac</creatorcontrib><creatorcontrib>Higginson, Michelle</creatorcontrib><creatorcontrib>Massah, Nasim</creatorcontrib><creatorcontrib>Miao, Fudan</creatorcontrib><creatorcontrib>Bhavsar, Amit</creatorcontrib><creatorcontrib>Lee, Jong</creatorcontrib><creatorcontrib>Bendyshe‐Walton, Tessa</creatorcontrib><creatorcontrib>Tanoshima, Reo</creatorcontrib><creatorcontrib>Johnson, David</creatorcontrib><creatorcontrib>Zhuwaki, Carnation</creatorcontrib><creatorcontrib>Honcharik, Nick</creatorcontrib><creatorcontrib>Jong, Geert‘t</creatorcontrib><creatorcontrib>Israels, Sara</creatorcontrib><creatorcontrib>Staub, Michelle</creatorcontrib><creatorcontrib>Rieder, Michael</creatorcontrib><creatorcontrib>Faught, Lauren</creatorcontrib><creatorcontrib>Ito, Shinya</creatorcontrib><creatorcontrib>Nathan, Paul</creatorcontrib><creatorcontrib>Karande, Smita</creatorcontrib><creatorcontrib>Vaillancourt, Régis</creatorcontrib><creatorcontrib>Johnston, Donna</creatorcontrib><creatorcontrib>Nguyen, Kimmy</creatorcontrib><creatorcontrib>Bussières, Jean‐François</creatorcontrib><creatorcontrib>Lebel, Denis</creatorcontrib><creatorcontrib>Jean‐Louis, Jennifer</creatorcontrib><creatorcontrib>Canadian Pharmacogenomics Network for Drug Safety Consortium</creatorcontrib><creatorcontrib>The Canadian Pharmacogenomics Network for Drug Safety Consortium</creatorcontrib><title>Pharmacogenomics of Vincristine‐Induced Peripheral Neuropathy Implicates Pharmacokinetic and Inherited Neuropathy Genes</title><title>Clinical pharmacology and therapeutics</title><addtitle>Clin Pharmacol Ther</addtitle><description>Vincristine is an effective chemotherapeutic drug for various cancers, including acute lymphoblastic leukemia (ALL). Unfortunately, clinical utility is restricted by dose‐limiting vincristine‐induced peripheral neuropathies (VIPN). We sought to determine the association of VIPN with a recently identified risk variant, CEP72 rs924607, and drug absorption, distribution, metabolism, and excretion (ADME) gene variants in pediatric ALL. This was followed by a meta‐analysis of pharmacogenomic data from over 500 patients. CEP72 rs924607 was significantly associated with VIPN (P = 0.02; odds ratio (OR) = 3.4). ADME analyses identified associations between VIPN and ABCC1 rs3784867 (P = 5.34 × 10−5; OR = 4.9), and SLC5A7 rs1013940 (P = 9.00 × 10−4; OR= 8.6); genes involved in vincristine transport and inherited neuropathies, respectively. Meta‐analysis identified an association with a variant related to TTPA (rs10504361: P = 6.85 × 10−4; OR = 2.0), a heritable neuropathy‐related gene. This study provides essential corroboratory evidence for CEP72 rs924607 and highlights the importance of drug transporter and inherited neuropathy genes in VIPN.</description><subject>Antineoplastic Agents, Phytogenic - pharmacokinetics</subject><subject>Antineoplastic Agents, Phytogenic - toxicity</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>Computational Biology</subject><subject>Female</subject><subject>Humans</subject><subject>Male</subject><subject>Microtubule-Associated Proteins - genetics</subject><subject>Multidrug Resistance-Associated Proteins - genetics</subject><subject>Peripheral Nervous System Diseases - chemically induced</subject><subject>Peripheral Nervous System Diseases - genetics</subject><subject>Pharmacogenetics</subject><subject>Tissue Distribution</subject><subject>Vincristine - pharmacokinetics</subject><subject>Vincristine - toxicity</subject><issn>0009-9236</issn><issn>1532-6535</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><sourceid>EIF</sourceid><recordid>eNp1kctO3DAUhi1EBVNA4glQlmwCx0mcxBukasRlJNTOAthajn3CuE3s1E5As-sj9Bl5kpqrpgu8sSx__-dj_YQcUjihANmpGsYTSiu-RWaU5VlaspxtkxkA8JRneblLvobwMx4LXtc7ZDfjcTFazsh6uZK-l8rdo3W9USFxbXJnrPImjMbi05-_C6snhTpZojfDCr3sku84eTfIcbVOFv3QGSVHDMm76lfMjUYl0upkYWPCjDG-kblEi2GffGllF_Dgbd8jtxfnN_Or9PrH5WL-7TpVBY3jNxVAU7cFrWqdy6rNW8o4apoVWoOChgJjDeS6RM5VxiGSVCotsdJ5yYDle-Ts1TtMTY9aoR3jF8TgTS_9WjhpxP831qzEvXsQJaMciiIKjt8E3v2eMIyiN0Fh10mLbgoig7LmGas2UeVdCB7bj2coiOemRGxKPDcV0aPNsT7A92oikL4Cj6bD9aciMV_evAj_ARD3ods</recordid><startdate>201902</startdate><enddate>201902</enddate><creator>Wright, Galen E.B.</creator><creator>Amstutz, Ursula</creator><creator>Drögemöller, Britt I.</creator><creator>Shih, Joanne</creator><creator>Rassekh, Shahrad R.</creator><creator>Hayden, Michael R.</creator><creator>Carleton, Bruce C.</creator><creator>Ross, Colin J.D.</creator><creator>Visscher, Henk</creator><creator>Aminkeng, Folefac</creator><creator>Higginson, Michelle</creator><creator>Massah, Nasim</creator><creator>Miao, Fudan</creator><creator>Bhavsar, Amit</creator><creator>Lee, Jong</creator><creator>Bendyshe‐Walton, Tessa</creator><creator>Tanoshima, Reo</creator><creator>Johnson, David</creator><creator>Zhuwaki, Carnation</creator><creator>Honcharik, Nick</creator><creator>Jong, Geert‘t</creator><creator>Israels, Sara</creator><creator>Staub, Michelle</creator><creator>Rieder, Michael</creator><creator>Faught, Lauren</creator><creator>Ito, Shinya</creator><creator>Nathan, Paul</creator><creator>Karande, Smita</creator><creator>Vaillancourt, Régis</creator><creator>Johnston, Donna</creator><creator>Nguyen, Kimmy</creator><creator>Bussières, Jean‐François</creator><creator>Lebel, Denis</creator><creator>Jean‐Louis, Jennifer</creator><general>John Wiley and Sons Inc</general><scope>24P</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>201902</creationdate><title>Pharmacogenomics of Vincristine‐Induced Peripheral Neuropathy Implicates Pharmacokinetic and Inherited Neuropathy Genes</title><author>Wright, Galen E.B. ; Amstutz, Ursula ; Drögemöller, Britt I. ; Shih, Joanne ; Rassekh, Shahrad R. ; Hayden, Michael R. ; Carleton, Bruce C. ; Ross, Colin J.D. ; Visscher, Henk ; Aminkeng, Folefac ; Higginson, Michelle ; Massah, Nasim ; Miao, Fudan ; Bhavsar, Amit ; Lee, Jong ; Bendyshe‐Walton, Tessa ; Tanoshima, Reo ; Johnson, David ; Zhuwaki, Carnation ; Honcharik, Nick ; Jong, Geert‘t ; Israels, Sara ; Staub, Michelle ; Rieder, Michael ; Faught, Lauren ; Ito, Shinya ; Nathan, Paul ; Karande, Smita ; Vaillancourt, Régis ; Johnston, Donna ; Nguyen, Kimmy ; Bussières, Jean‐François ; Lebel, Denis ; Jean‐Louis, Jennifer</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4109-b700b8f4178d3a7f3f159ed124dd0c0b1055b03d6e99c290f411acdae7d365053</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Antineoplastic Agents, Phytogenic - pharmacokinetics</topic><topic>Antineoplastic Agents, Phytogenic - toxicity</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>Computational Biology</topic><topic>Female</topic><topic>Humans</topic><topic>Male</topic><topic>Microtubule-Associated Proteins - genetics</topic><topic>Multidrug Resistance-Associated Proteins - genetics</topic><topic>Peripheral Nervous System Diseases - chemically induced</topic><topic>Peripheral Nervous System Diseases - genetics</topic><topic>Pharmacogenetics</topic><topic>Tissue Distribution</topic><topic>Vincristine - pharmacokinetics</topic><topic>Vincristine - toxicity</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wright, Galen E.B.</creatorcontrib><creatorcontrib>Amstutz, Ursula</creatorcontrib><creatorcontrib>Drögemöller, Britt I.</creatorcontrib><creatorcontrib>Shih, Joanne</creatorcontrib><creatorcontrib>Rassekh, Shahrad R.</creatorcontrib><creatorcontrib>Hayden, Michael R.</creatorcontrib><creatorcontrib>Carleton, Bruce C.</creatorcontrib><creatorcontrib>Ross, Colin J.D.</creatorcontrib><creatorcontrib>Visscher, Henk</creatorcontrib><creatorcontrib>Aminkeng, Folefac</creatorcontrib><creatorcontrib>Higginson, Michelle</creatorcontrib><creatorcontrib>Massah, Nasim</creatorcontrib><creatorcontrib>Miao, Fudan</creatorcontrib><creatorcontrib>Bhavsar, Amit</creatorcontrib><creatorcontrib>Lee, Jong</creatorcontrib><creatorcontrib>Bendyshe‐Walton, Tessa</creatorcontrib><creatorcontrib>Tanoshima, Reo</creatorcontrib><creatorcontrib>Johnson, David</creatorcontrib><creatorcontrib>Zhuwaki, Carnation</creatorcontrib><creatorcontrib>Honcharik, Nick</creatorcontrib><creatorcontrib>Jong, Geert‘t</creatorcontrib><creatorcontrib>Israels, Sara</creatorcontrib><creatorcontrib>Staub, Michelle</creatorcontrib><creatorcontrib>Rieder, Michael</creatorcontrib><creatorcontrib>Faught, Lauren</creatorcontrib><creatorcontrib>Ito, Shinya</creatorcontrib><creatorcontrib>Nathan, Paul</creatorcontrib><creatorcontrib>Karande, Smita</creatorcontrib><creatorcontrib>Vaillancourt, Régis</creatorcontrib><creatorcontrib>Johnston, Donna</creatorcontrib><creatorcontrib>Nguyen, Kimmy</creatorcontrib><creatorcontrib>Bussières, Jean‐François</creatorcontrib><creatorcontrib>Lebel, Denis</creatorcontrib><creatorcontrib>Jean‐Louis, Jennifer</creatorcontrib><creatorcontrib>Canadian Pharmacogenomics Network for Drug Safety Consortium</creatorcontrib><creatorcontrib>The Canadian Pharmacogenomics Network for Drug Safety Consortium</creatorcontrib><collection>Wiley Online Library Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Clinical pharmacology and therapeutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wright, Galen E.B.</au><au>Amstutz, Ursula</au><au>Drögemöller, Britt I.</au><au>Shih, Joanne</au><au>Rassekh, Shahrad R.</au><au>Hayden, Michael R.</au><au>Carleton, Bruce C.</au><au>Ross, Colin J.D.</au><au>Visscher, Henk</au><au>Aminkeng, Folefac</au><au>Higginson, Michelle</au><au>Massah, Nasim</au><au>Miao, Fudan</au><au>Bhavsar, Amit</au><au>Lee, Jong</au><au>Bendyshe‐Walton, Tessa</au><au>Tanoshima, Reo</au><au>Johnson, David</au><au>Zhuwaki, Carnation</au><au>Honcharik, Nick</au><au>Jong, Geert‘t</au><au>Israels, Sara</au><au>Staub, Michelle</au><au>Rieder, Michael</au><au>Faught, Lauren</au><au>Ito, Shinya</au><au>Nathan, Paul</au><au>Karande, Smita</au><au>Vaillancourt, Régis</au><au>Johnston, Donna</au><au>Nguyen, Kimmy</au><au>Bussières, Jean‐François</au><au>Lebel, Denis</au><au>Jean‐Louis, Jennifer</au><aucorp>Canadian Pharmacogenomics Network for Drug Safety Consortium</aucorp><aucorp>The Canadian Pharmacogenomics Network for Drug Safety Consortium</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Pharmacogenomics of Vincristine‐Induced Peripheral Neuropathy Implicates Pharmacokinetic and Inherited Neuropathy Genes</atitle><jtitle>Clinical pharmacology and therapeutics</jtitle><addtitle>Clin Pharmacol Ther</addtitle><date>2019-02</date><risdate>2019</risdate><volume>105</volume><issue>2</issue><spage>402</spage><epage>410</epage><pages>402-410</pages><issn>0009-9236</issn><eissn>1532-6535</eissn><abstract>Vincristine is an effective chemotherapeutic drug for various cancers, including acute lymphoblastic leukemia (ALL). Unfortunately, clinical utility is restricted by dose‐limiting vincristine‐induced peripheral neuropathies (VIPN). We sought to determine the association of VIPN with a recently identified risk variant, CEP72 rs924607, and drug absorption, distribution, metabolism, and excretion (ADME) gene variants in pediatric ALL. This was followed by a meta‐analysis of pharmacogenomic data from over 500 patients. CEP72 rs924607 was significantly associated with VIPN (P = 0.02; odds ratio (OR) = 3.4). ADME analyses identified associations between VIPN and ABCC1 rs3784867 (P = 5.34 × 10−5; OR = 4.9), and SLC5A7 rs1013940 (P = 9.00 × 10−4; OR= 8.6); genes involved in vincristine transport and inherited neuropathies, respectively. Meta‐analysis identified an association with a variant related to TTPA (rs10504361: P = 6.85 × 10−4; OR = 2.0), a heritable neuropathy‐related gene. This study provides essential corroboratory evidence for CEP72 rs924607 and highlights the importance of drug transporter and inherited neuropathy genes in VIPN.</abstract><cop>United States</cop><pub>John Wiley and Sons Inc</pub><pmid>29999516</pmid><doi>10.1002/cpt.1179</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0009-9236
ispartof Clinical pharmacology and therapeutics, 2019-02, Vol.105 (2), p.402-410
issn 0009-9236
1532-6535
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6519044
source MEDLINE; Wiley Online Library Journals Frontfile Complete
subjects Antineoplastic Agents, Phytogenic - pharmacokinetics
Antineoplastic Agents, Phytogenic - toxicity
Child
Child, Preschool
Computational Biology
Female
Humans
Male
Microtubule-Associated Proteins - genetics
Multidrug Resistance-Associated Proteins - genetics
Peripheral Nervous System Diseases - chemically induced
Peripheral Nervous System Diseases - genetics
Pharmacogenetics
Tissue Distribution
Vincristine - pharmacokinetics
Vincristine - toxicity
title Pharmacogenomics of Vincristine‐Induced Peripheral Neuropathy Implicates Pharmacokinetic and Inherited Neuropathy Genes
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-10T09%3A57%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Pharmacogenomics%20of%20Vincristine%E2%80%90Induced%20Peripheral%20Neuropathy%20Implicates%20Pharmacokinetic%20and%20Inherited%20Neuropathy%20Genes&rft.jtitle=Clinical%20pharmacology%20and%20therapeutics&rft.au=Wright,%20Galen%20E.B.&rft.aucorp=Canadian%20Pharmacogenomics%20Network%20for%20Drug%20Safety%20Consortium&rft.date=2019-02&rft.volume=105&rft.issue=2&rft.spage=402&rft.epage=410&rft.pages=402-410&rft.issn=0009-9236&rft.eissn=1532-6535&rft_id=info:doi/10.1002/cpt.1179&rft_dat=%3Cproquest_pubme%3E2068925744%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2068925744&rft_id=info:pmid/29999516&rfr_iscdi=true